About this raise

Surgical Theater, with a valuation of $75 million, is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed software that combines flight simulation with CT/MRI imaging technology. The technology allows surgeons to perform simulation of surgeries before the actual operation. The Surgery Rehearsal Platform of Surgical Theater is the only patented and FDA-cleared platform for cerebral and spine pre-surgery rehearsal. Moty Avisar and Alon Geri founded Surgical Theater in 2010. The current crowdfunding campaign has a minimum target of $11,200 and a maximum target of $2.23 million. The campaign proceeds will be used for growth and expansion.

Expand

Investment Overview

Invested this round: $576,732

Deal Terms

Platform
OurCrowd
Start Date
01/05/2023
Close Date
03/13/2023
Min. Goal
$11,200
Max Goal
$2,230,000
Min. Investment

$11,200

Security Type

Convertible Note

Company Stage

Growth Stage

SEC Filing Type

RegD 506(c)

Valuation Cap

$75,000,000

Discount

0%

Company & Team

Company

Year Founded
2010
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Location
Los Angeles, California
Company Website
Visit Website

Team

Funding data not publicly available

Financials

Financials are not currently available for this company. This may occur if the company is still Testing the Waters, is a Regulation D offering, or if the financials are still under review and being confirmed by our team. For Reg CF and Reg A+ raises, please check back later.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
03/13/2023 OurCrowd $75,000,000 $576,732 Convertible Note Funded RegD 506(c)
06/18/2021 OurCrowd $162,000,000 $221,876 Equity - Common Funded RegD 506(c)
02/10/2020 OurCrowd $140,000,000 $1,587,253 Equity - Common Funded RegD 506(c)
04/03/2017 OurCrowd $55,000,000 $2,264,576 Equity - Common Funded RegD 506(c)
08/19/2015 OurCrowd - $175,277 Equity - Common Funded RegD 506(c)
01/12/2014 OurCrowd - $1,100,000 Equity - Common Funded RegD 506(c)
04/02/2013 OurCrowd - $577,500 Equity - Common Funded RegD 506(c)
Create a free account today to gain access to Kingscrowd analytics.

Growth Charts

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Employee History

Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Surgical Theater on OurCrowd 2023
Platform: OurCrowd
Security Type: Convertible Note
Valuation: $75,000,000

Follow company

Follow Surgical Theater on OurCrowd 2023

Buy Surgical Theater's Deal Report

Warning: according to the close date for this deal, Surgical Theater may no longer be accepting investments.

Surgical Theater Deal Report

Get Kingscrowd's comprehensive report on Surgical Theater including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Surgical Theater is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Surgical Theater deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge